BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1677013)

  • 1. Eosinophil infiltration: effects of H1 antihistamines.
    Fadel R; David B; Rassemont R; Herpin-Richard N; Borgnon A; Rihoux JP
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1094-6. PubMed ID: 1677013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man.
    Fadel R; David B; Herpin-Richard N; Borgnon A; Rassemont R; Rihoux JP
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):314-20. PubMed ID: 1976664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo.
    Fadel R; Herpin-Richard N; Rihoux JP; Henocq E
    Clin Allergy; 1987 Jul; 17(4):373-9. PubMed ID: 2887304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.
    Michel L; De Vos C; Rihoux JP; Burtin C; Benveniste J; Dubertret L
    J Allergy Clin Immunol; 1988 Jul; 82(1):101-9. PubMed ID: 2899102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cetirizine to investigate non-H1 effects of second-generation antihistamines.
    Townley RG; Okada C
    Ann Allergy; 1992 Feb; 68(2):190-6. PubMed ID: 1346737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine.
    Zweiman B; Atkins PC; Moskovitz A; von Allmen C; Ciliberti M; Grossman S
    J Allergy Clin Immunol; 1997 Sep; 100(3):341-7. PubMed ID: 9314346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
    Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
    Allergy; 2000 Sep; 55(9):888-91. PubMed ID: 11003455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study.
    Nielsen PN; Skov PS; Poulsen LK; Schmelz M; Petersen LJ
    Clin Exp Allergy; 2001 Sep; 31(9):1378-84. PubMed ID: 11591187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade.
    Rihoux JP
    Agents Actions Suppl; 1991; 33():409-15. PubMed ID: 1675836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional properties of cetirizine, a new H1 antagonist.
    Naclerio RM
    Allergy Proc; 1991; 12(3):187-91. PubMed ID: 1680095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
    Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
    Allergy; 2000 Apr; 55(4):382-5. PubMed ID: 10782524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: effects of cetirizine.
    Atkins PC; Zweiman B; Moskovitz A; von Allmen C; Ciliberti M
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):806-11. PubMed ID: 9215249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro.
    Okada C; Eda R; Miyagawa H; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
    Int Arch Allergy Immunol; 1994; 103(4):384-90. PubMed ID: 8130652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells.
    Amon U; Gibbs BF; Buss G; Nitschke M
    Inflamm Res; 2000 Mar; 49(3):112-6. PubMed ID: 10807498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80.
    Martins MA; Pasquale CP; e Silva PM; Pires AL; Ruffié C; Rihoux JP; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1992 Jan; 105(1):176-80. PubMed ID: 1350745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diphenhydramine and cetirizine on immediate and late-phase cutaneous allergic reactions in healthy dogs: a randomized, double-blinded crossover study.
    Banovic F; Denley T; Blubaugh A; Scheibe I; Lemo N; Papich MG
    Vet Dermatol; 2020 Aug; 31(4):256-e58. PubMed ID: 31899570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetirizine and loratadine: a comparison using the ED50 in skin reactions.
    Ramboer I; Bumtbacea R; Lazarescu D; Radu JR
    J Int Med Res; 2000; 28(2):69-77. PubMed ID: 10898119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study.
    Snyman JR; Sommers DK; Gregorowski MD; Boraine H
    Eur J Clin Pharmacol; 1992; 42(4):359-62. PubMed ID: 1355426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
    Leprevost C; Capron M; De Vos C; Tomassini M; Capron A
    Int Arch Allergy Appl Immunol; 1988; 87(1):9-13. PubMed ID: 2971624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.